Res. Asst. PhD AYŞE PINAR ERÇETİN

Publication Network

Articles 23

1. The Effect of Adipocyte-Derived Stem Cell Media on Stem Cell Markers in Neuroblastoma Cells

Ozsengezer S. K., ALTUN Z. S., Serinan E., AKTAŞ S., Ercetin P., Olgun N.

JOURNAL OF BEHCET UZ CHILDRENS HOSPITAL , vol.15, no.1, pp.24-34, 2025 (ESCI)

2. ATTITUDES AND PERSPECTIVES OF ASSOCIATE STUDENTS ON SMOKING USE AND ITS DAMAGES: THE CASE OF HEALTH SERVICES VOCATIONAL SCHOOL

Erçetin A. P., Erçal T.

Journal of Pre-Hospital - Hastane Öncesi Dergisi , vol.8, no.1, pp.1-11, 2023 (Peer-Reviewed Journal)

3. Noroblastomda Molekuler Heterojenite Ve Klinik Onemi - Molecular Heterogeneity In Neuroblastoma And Its Clinical Significance

Aktaş T. Ç., Aktaş S., Serinan E. Ö., Erçetin A. P., Aydın M., Gökbayrak Ö. E., et al.

Journal of Dr. Behcet Uz Children's Hospital , vol.14238, pp.1-5, 2023 (ESCI)

4. Evaluation of the Effect of Mesenchymal Stem Cells on Cisplatin Induced Toxicity in Neuroblastoma Tumor Model

AKTAŞ S., OLGUN Y., EVİN H., ERÇETİN A. P., Aktaş T., YILMAZ O., et al.

International Journal of Medical Science and Clinical Invention , vol.8, no.16, pp.5836-5848, 2021 (Peer-Reviewed Journal)

5. Effect of Tacrolimus in Triple Negative Breast Cancer Animal Model

Aktaş S., Erçetin A. P., Kolatan H. E.

International Journal of Clinical and Experimental Medicine Research , vol.5, no.3, pp.269-277, 2021 (Peer-Reviewed Journal)

6. The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study

Ozcan Y., Caglar F., ÇELİK S., Demir A. B., ERÇETİN A. P., Altun Z. S., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.38, no.5, pp.476-487, 2020 (SCI-Expanded, Scopus) Sustainable Development

7. Effect of Mesenchymal Stem Cells on Cochlear Cell Viability After Cisplatin Induced Ototoxicity

Erçetin A. P., Olgun Y., Aktaş S., Aydin M., Evin Eskicioğlu H., Altun Z. S., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.4, no.3, pp.378-383, 2020 (ESCI)

8. MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance

Ecevit C. O., Aktaş S., Yildirim H. T., Demirag B., Erbay A., Karaca I., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.41, no.1, pp.7-12, 2019 (SCI-Expanded)

9. Molecular Heterogenity in Neuroblastoma

Aktas T. C., Serinan E., Ercetin A. P., Aydin M., Gokbayrak O., Erol A., et al.

PEDIATRIC BLOOD & CANCER , vol.65, 2018 (SCI-Expanded)

10. Withaferin-A: A candidate anti-tumor natural compound for non-small cell lung cancer

ERÇETİN A. P., AYDIN M., GENCKURT E., KAFALI Y., HIDIR S., AKTAŞ S.

ESMO OPEN , vol.3, no.2, pp.135, 2018 (Scopus) Sustainable Development

11. The Importance of Investigating Tumor Biology and Biomarkers in Pleural Effusions

Görgülü B., Akkoçlu A., AKTAŞ S., ALTUN Z. S., DEMİR A. B., Pamukoğlu A., et al.

Journal of Molecular Biomarkers Diagnosis , vol.9, no.05, 2018 (Peer-Reviewed Journal)

12. Effect of Tacrolimus on Triple Negative Breast Cancer Animal Model

AKTAŞ S., ERÇETİN A. P., KOLATAN H. E., YILMAZ O.

Turkish Journal of Molecular Biology Biotechnology , vol.1, no.01, pp.158, 2017 (Peer-Reviewed Journal) Sustainable Development

13. Chronic Myeloid Leukemia Stem Cell Line Production

ÖZTÜRK S., ERÇETİN A. P., AKTAŞ S., DURSUN D., ÖZCAN M. A.

Journal of Cancer Stem Cell Research , vol.5, no.1002, 2017 (Peer-Reviewed Journal)

14. Evaluation of Circulating Tumour Cell Load in Neuroblastoma (on behalf of Turkish Paediatric Oncology Group)

Aktas S., Ercetin A. P., Celik E., ALTUN Z. S., Demir A. B., Olgun N.

PEDIATRIC BLOOD & CANCER , vol.63, 2016 (SCI-Expanded)

15. Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients.

OLGUN Y., AKTAŞ S., ALTUN Z. S., KIRKIM G., Kizmazoglu D., ERÇETİN A. P., et al.

International journal of pediatric otorhinolaryngology , vol.90, pp.64-69, 2016 (SCI-Expanded, Scopus)

16. Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma

ERÇETİN A. P., ÖZCAN M. A., AKTAŞ S., YÜKSEL F., Solmaz S. M., Sevindik G. O., et al.

EXPERIMENTAL HEMATOLOGY , vol.44, no.4, pp.223-230, 2016 (SCI-Expanded) Sustainable Development

17. HER2 positivity is increasing according to the ASCO CAP 2013 criteria

ELİYATKIN N., Özgür H., ERÇETİN A. P., AKTAŞ S., Küpelioğlu A., Zengel B., et al.

The Journal of Tepecik Education and Research Hospital , vol.26, no.2, pp.133-138, 2016 (Peer-Reviewed Journal)

18. Gene expression characteristics of breast cancer stem cells

DOĞAN S. M., ERÇETİN A. P., ALTUN Z. S., Dursun D., AKTAŞ S.

JOURNAL OF BUON , vol.20, no.5, pp.1304-1313, 2015 (SCI-Expanded, Scopus) Sustainable Development

19. The Evaluation of HER 2 Status with Immunohistochemical and Molecular Analyses In Breast Carcinomas

ELİYATKIN N., ÖZGÜR H., ERÇETİN A. P., AKTAŞ S., KÜPELİOĞLU A.

The Journal of Tepecik Education and Research Hospital , vol.25, no.1, pp.19-27, 2015 (Peer-Reviewed Journal)

20. Meme karsinomlarındaHER 2 durumunun immunhistokimyasal ve moleküler analizlerle değerlendirilmesi

Eliyatkın N., Özgür H., ERÇETİN A. P., AKTAŞ S., Küpelioğlu A.

İzmir Tepecik Eğitim ve Araştırma Hastanesi Dergisi , vol.25, no.1, pp.19-27, 2015 (Peer-Reviewed Journal)

21. Regulatory T Cells and Their Prognostic Value in Hepatopancreatobiliary Tumours

Ozgur H. H., ERÇETİN A. P., Eliyatkin N., Seren A., Kupelioglu A., Ortac R., et al.

HEPATO-GASTROENTEROLOGY , vol.61, no.135, pp.1847-1851, 2014 (SCI-Expanded) Sustainable Development

22. Nörofibromatozis Tip 1 Olgularında Dna Tamir Genlerinin Ekspresyonunun Klinik Önemi Clınıcal Sıgnıfıcance Of Dna Repaır Genes Expressıons In Neurofıbromatosıs Type 1 Cases Duygu Dursun1 Safiye Aktaş1 Ayşe Pınar Erçetin1 Zekiye Altun1 Kamer Mutafoğlu2 Nur Olgun2

DUYGU D., AKTAŞ S., ERÇETİN A. P., ALTUN Z. S., MUTAFOĞLU K., OLGUN H. N.

Nörofibromatozis Tip 1 Olgularında Dna Tamir Genlerinin Ekspresyonunun Klinik Önemi , vol.27, no.1, pp.15-23, 2013 (Peer-Reviewed Journal)

23. The correlation between T regulatory cells and autologous peripheral blood stem cell transplantation in multiple myeloma

Erçetin A. P., Aktaş S., Piskin O., Ateş H., Zadeoglulari Z. F., Turgut N. H., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.28, no.2, pp.107-114, 2011 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 55

1. Effect of MSCs on Cisplatin Toxicity in Neuroblastoma Model

AKTAŞ S., EVİN ESKİCİOĞLU H., ERÇETİN A. P., Aktaş T., YILMAZ O., KIRKIM G., et al.

3. International Baku Scientific Research Congress The Book of Full Text, Baku, Azerbaijan, 13 July 2021, pp.801-816, (Full Text)

2. EVALUATION OF THE EFFECT OF MESENCHYMAL STEM CELLS ON CISPLATIN INDUCED TOXICITY IN NEUROBLASTOMA TUMOR MODEL

AKTAŞ S., OLGUN Y., KIRKIM G., EVİN ESKİCİOĞLU H., ERÇETİN A. P., Aktaş T. Ç., et al.

3. INTERNATIONAL BAKU SCIENTIFIC RESEARCH CONGRESS, Baku, Azerbaijan, 15 - 16 October 2021, (Full Text)

3. PO-392 Mesenchimal Stem Cell and Cisplatin Interference in Neuroblastoma Experimental Animal Model

AKTAŞ S., ERÇETİN A. P., AYDIN M., ÇALİŞİR M., BEKÇİOĞLU Ö., YILMAZ O., et al.

50th Congress of the International Society of Pediatric Oncolog, Kyoto, Japan, 14 - 16 November 2018, (Summary Text)

4. “Don’t Eat Me” Signals of Neuroblastoma by CD47 for Immune Escape: A Novel Prognostic Biomarker

AKTAŞ S., ERÇETİN A. P., Serinan E., ALTUN Z. S., OLGUN H. N.

2nd International Cell Death and Research Congress, 1 - 04 November 2018, vol.2, pp.1538, (Full Text)

5. Optimisation of Xenograft Cancer Modelling in Mice

ERÇETİN A. P., AYDIN M., BEKÇİOGLU Ö., KOLATAN H. E., GÖKBAYRAK Ö., EROL A., et al.

7. Multidisipliner Kanser Araştırma 1. Temel Onkoloji Kongresi (Uluslarlar arası katılımlı), 11 - 14 October 2018, (Full Text) Sustainable Development

6. Examining Microenvironment in Osteosarcoma: Bone Greft Material Cement Does Not interfere with chemo and immunotherapy in osteosarcoma

BEKCİOGLU O., AKTAŞ S., ERÇETİN A. P., AYDIN M., KOLATAN H. E., KILIC A. İ., et al.

7. Multidisipliner Kanser Araştırma 1. Temel Onkoloji Kongresi Uluslararası Katılımlı, 11 - 14 October 2018, (Full Text)

7. Experimental Mouse Models: What can be learnt about tumor immunology?

ERÇETİN A. P.

7. Multidisipliner Kanser Araştırma 1. Temel Onkoloji Kongresi (Uluslararası Katılımlı), Turkey, 11 - 14 October 2018, (Full Text)

8. Dizi Analizi Metodları, Tanımlar, Tarihçe

ERÇETİN A. P.

1. Temel Onkoloji Sempozyumu, Turkey, 9 - 11 May 2018, (Full Text)

9. ın vivo presentation locaL EFFECT OF CADMİUM OF LOCAL RECCURENCE İN XENOGRAFT MODEL OF OSTEOSARCOMA

DEMİRKIRAN D., AKTAŞ S., ERÇETİN A. P., KOLATAN H. E., YILMAZ O., HA H., et al.

sıop 2017, Washington, Kiribati, 12 - 15 October 2017, vol.64, pp.253, (Summary Text)

10. the effects of rosiglitazone on minimal disease model of neuroblastoma

ALTUN Z. S., ayla M., pamukoğlu a., ERÇETİN A. P., OLGUN H. N.

SIOP 2017, 12 - 15 October 2017, vol.64, pp.223, (Summary Text)

11. the relation of microenvironment associated gene expression with risk classification in neuroblastoma

AKTAŞ S., ERÇETİN A. P., serinan e., aydın m., ALTUN Z. S., OLGUN H. N.

SIOP 2017, 12 - 15 October 2017, vol.64, pp.222, (Summary Text)

12. Effect of Mesenchymal stem cells on Cochlear cell Viability after Cisplatin Induced Ototoxicity

ERÇETİN A. P., OLGUN Y., AKTAŞ S., aydın m., EVİN H., ALTUN Z. S., et al.

APSCI 2017, 19 - 22 September 2017, (Summary Text)

13. Effect of mesenchymal stem cells on cochlear cell viability after cisplatin induced ototxicity

ERÇETİN A. P., OLGUN Y., AKTAŞ S., aydın m., evin h., ALTUN Z. S., et al.

11t APSCI 2017, 19 - 22 September 2017, (Summary Text)

14. Effect of Mesenchymal Stem Cell on Cochlear Cell Viability After Cisplatin Induced Ototoxicity

ERÇETİN A. P., OLGUN Y., AKTAŞ S., Aydın M., EVİN H., ALTUN Z. S., et al.

APSCI 2017, 19 - 22 September 2017, (Summary Text)

15. EFFECTS OF MESENCHYMAL STEM CELLS TUMOR INFILTRATING LYMPHOCYTESAND CANCER STEM CELLS İN THE NEUROBLASTOMA

EKİN Z., AKTAŞ S., ALTUN Z. S., SERİNAN E., ERÇETİN A. P., EKİN r., et al.

29TH eUROPEAN CONGRESS OF PATHOLOGY, 2 - 04 September 2017, vol.471, pp.352, (Summary Text) Sustainable Development

16. Effect of Tacrolimus on Triple Negative Reast Cancer Anemal Model

AKTAŞ S., ERÇETİN A. P., KOLATAN H. E., YILMAZ O.

VI.İnternational Cogress Molecular medicine, İstanbul, Turkey, 22 - 25 May 2017, (Summary Text) Sustainable Development

17. Effect of Tacrolimus on Triple Negative Breast Cancer Animal Model

AKTAŞ S., ERÇETİN A. P., KOLATAN H. E., YILMAZ O.

VI. International Congress of Molecular Medicine, İstanbul, Turkey, 22 - 25 May 2017, pp.309, (Summary Text) Sustainable Development

18. EVALUATION OF CYTOKINE LEVELS, TREGS AND MYELOMA CELLS IN DIFFERENT MICROENVIRONMENTS

ERÇETİN A. P., BAM R., YACCOBY S.

6th International Congress on Leukemia Lymphoma Myeloma, 11 - 13 May 2017, pp.115, (Summary Text)

19. Can High Risk Group Be Categorized As High Risk And Ultra High Risk In Neuroblastoma

Demir A. B., Aktaş S., Altun Z. S., Erçetin A. P., Olgun H. N.

48th CONGRESS OF THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201, (Summary Text)

20. The Effects of Acetyl L Carnitine on Cisplatin and Radietion Induced Apoptosis Treatment on Medulloblastoma Cells

PAMUKOĞLU KAYNAR A., ALTUN Z. S., ERÇETİN A. P., OLGUN Y., ÇETİNAYAK H. O., AKTAŞ S., et al.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.57, (Summary Text)

21. Anti Proliferative and Apoptosis Inducing Effect of Flubendazole on Neuroblastoma Cells

ERÇETİN A. P., ALTUN Z. S., AYDIN M., BOSKAN G., GÖKDEMİR E., KAVAK İ., et al.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.189, (Summary Text)

22. In vitro Effect of Flubendazole on Neuroblastoma Stem Cells

ERÇETİN A. P., AKTAŞ S., GENÇ N., SERİNAN E., ALTUN Z. S., OLGUN H. N.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.125, (Summary Text)

23. The in vitro Effect of Sanguinarine Differs on Neuroblastoma Stgem Cells based on the serum

ERÇETİN A. P., AKTAŞ S., YAVUZ B., ÖZTÜRK T., KAMAN D., SULU M., et al.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.49, (Summary Text)

24. In vitro Effect of Borate Derivatives on Neuroblastoma Cells

ERÇETİN A. P., AKTAŞ S., AYDIN M., SOMEN M., PAŞAYİĞİT M., OLGUN H. N., et al.

6.Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.190, (Summary Text)

25. Oncomir miR17 Tumour Suppressor miR146a miR302d and Oncogene miR19B Expression in Hepatoblastoma Patients

ECEVİT Ç., AKTAŞ S., YILDIRIM H., DEMİRAĞ B., ERBAY A., KARACA İ., et al.

The 48th Congress of the International Society of Paedriatric Oncology (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.237, (Summary Text)

26. Evaluation of Circulating Tumor Cell Load in Neuroblastoma on behalf of Turkish Paediatric Oncology Group

AKTAŞ S., ERÇETİN A. P., ÇELİK E., ALTUN Z. S., DEMİR A. B., OLGUN H. N.

The 48th Congress of International Society of Paediatric Oncology (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201, (Summary Text)

27. Can High Risk Group be Categorized as High Risk and Ultra High Risk in Neuroblastoma on behalf of Turkish Society of Paediatric Oncology Group

DEMİR A. B., AKTAŞ S., ALTUN Z. S., ERÇETİN A. P., OLGUN H. N.

The 48th Congress of the International Society of Paedriatric Oncology (SIOP), 19 - 22 October 2016, vol.63, pp.200, (Summary Text)

28. Effect of Mesenchymal Stem Cells and Tumour InfiltratingLymphocytes on Cancer Stem Cells in Neuroblastoma on behalf of TurkishPaediatric Oncology Group

YILDIRIM EKİN Z., AKTAŞ S., ERÇETİN A. P., ALTUN Z. S., Serinan E., DEMİR A. B., et al.

SİOP, 19 December - 22 October 2016 Sustainable Development

29. Effect of Mesenchymal Stem Cells and Tumor Infiltrating Lymphocytes on Cancer Stem Cells in Neuroblastoma on behalf of Turkish Paediatric Oncology Group

YILDIRIM EKİN Z., AKTAŞ S., ERÇETİN A. P., ALTUN Z. S., SERİNAN E., DEMİR A. B., et al.

The 48th Congress of the International Society of Paediatric Oncology (SIOP 2016), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201 Sustainable Development